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Abstract 
 
Background. Whether the presence of the Apolipoprotein E İ4 allele modulates hippocampal 
connectivity networks in abnormal ageing has yet to be fully clarified.   
Objective. Allele-dependent differences in this pattern of functional connectivity were investigated 
in patients with very mild QHXURGHJHQHUDWLRQRIWKH$O]KHLPHU¶VW\SH carriers and non-carriers of 
the İ4 allele.  
Method. A seed-based connectivity approach was used.  The two groups were similar in 
demographics, volumetric measures of brain-structure, and cognitive profiles. 
Results. İ4 carriers had increased connectivity between the seed area in the left hippocampus and 1) 
a left insular/lateral prefrontal region and 2) the contralateral right parietal cortex.  Moreover, 
hippocampus-to-parietal connectivity in the JURXSRIİ4 carriers was positively associated with 
memory performance, indicating that the between-group difference reflects compensatory 
processes.  Retrospective analyses of functional connectivity based on patients from the ADNI 
initiative confirmed this pattern. 
Conclusion. We suggest that increased connectivity with extra-DMN areas reflects both 
compensatory recruitment of additional areas, and pathological interwining between the DMN and 
the VDOLHQFHQHWZRUNDVSDUWRIDJOREDOİ4-dependent circuital disruption.  These differences indicate 
WKDWWKHİ4 allele is associated with a more profound degree of DMN network breakdown even in the 
prodromal stage of neurodegeneration. 
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1. Introduction 
The brain default-mode network (DMN) is a functional resting-state circuit that normally activates 
while a person does not engage in any explicit mental task [1].  It includes midline kernels localised 
in the posterior cingulate and medial prefrontal cortices, which are connected functionally with the 
inferior parietal lobule, the lateral temporal cortex, and the hippocampal formation [2].  $O]KHLPHU¶V
disease (AD) causes a global disruption of functional connectivity within the DMN [3].  Further 
segmentation of the circuit into sub-components suggests that AD down-regulates connectivity 
within the structures located in the posterior portion of the DMN and up-regulates connectivity of 
the prefrontal hubs [4-5].  This process begins in prodromal AD, when the disease is characterised 
by a transitional phase of Mild Cognitive Impairment (MCI) [6-7].  Within the set of regions 
included within the DMN, the hippocampus plays a distinguishing role.  In fact, hippocampal 
subfields are subjected to a well-established volumetric loss along the timeline of AD [8], and this 
shrinkage is predictive of conversion from MCI to the dementia stage [9].  Morevoer, when 
compared with healthy controls, patients diagnosed with amnestic MCI (thus suggestive of potential 
AD) show disrupted connectivity, with pathological up-regulation of connectivity within the 
hippocampal formation and between the hippocampus and the posterior-cingulate/precuneus region 
[10].  Modifications of memory-associated patterns of hippocampal activation have been also 
UHSRUWHGLQ0&,>@DQGWKLVDVSHFWZDVIRXQGWREHDVVRFLDWHGZLWKFRUWLFDOWKLQQLQJRI³VLJQDWXUH
UHJLRQV´RI$'LQFOXGLQJIURQWDOWHPSRUDODQGSDULHWDOFRUWLFHV>@ 
7KHİ4 isoform of the Apolipoprotein E (ApoE) gene is a well-established risk factor for the 
development of the sporadic late-onset forms of AD [13-14], and is associated with a younger age 
of disease onset [15].  The homonymous peptide coded by the gene plays a crucial role in 
lipoprotein metabolism and neurobiology [16].  As for the latter set of functions, the ApoE İ4 allele 
appears responsible for a large number of detrimental effects on neuronal and synaptic function, in 
FRPSDULVRQZLWKWKH³VWDQGDUG´İ3 isoform [17], and appears to exert its impact on cell biology both 
either in the presence or in the absence of neurodegeneration [18].  Following the Imaging Genetics 
model, the direct effect of the various ApoE isoforms on cellular mechanisms translates into 
indirect, yet consequent, effects of the genotype on the development of brain structure and brain 
function [19].  Within this latter category of variables, a large number of studies on healthy adults 
KDYHIRXQGWKDWWKHİ4 isoform is associated with alterations of the DMN both in healthy ageing and 
young adulthood [20-28], in correspondence or even prior to the initiation of the neuropathological 
cascade seen in AD.  Conversely, the study of WKHLPSDFWRIWKHİ4 allele on functional connectivity 
in the symptomatic stages of AD has been scarce.  A few studies investigated electro- and magneto-
6 
 
 
encephalographic connectivity in samples of MCI and mildly-to-moderately demented AD patients.  
These UHYHDOHGWKDWWKHİ4 isoform is associated with decreased levels of functional connectivity as 
measured by various proxies of connectivity such as signal coherence, synchronisation likelihood, 
and ROI-based lagged-phase synchronisation [29-32].  Aside from well-established limits in spatial 
resolution, however, these techniques do not allow a specific focus on all major DMN hubs affected 
by AD, as these are located in regions that are not easily capturable by measurements obtained at 
the scalp level.  Overcoming these methodological limitations, two very recent rest-fMRI studies 
IRXQGWKDWWKH'01RIİ4 patients diagnosed with early-stage AD is significantly down-regulated 
[33-34].  Despite the limited number of studies, this body of evidence indicates that the presence of 
WKHİ4 allele impacts negatively on DMN integrity even after the onset of a clinically-established 
symptomatology of dementia.  Nevertheless, it is still undetermined whether variability for the 
ApoE genotype is associated with a distinctive signature of disruption of hippocampal functional 
connectivity in the prodromal phases of the disease, when the person still retains their daily life 
independence.  The hippocampus, harshly affected in AD, is of particular interest in this early phase 
of the disease.  In fact, this stage is crucial because it represents the earliest moment of 
subjective/objective awareness of the presence of a possible neurodegenerative disease.  In addition, 
published studies suggest that this clinical stage is associated with a high degree of retained 
mechanisms of neuroplasticity, sufficient to induce remarkable changes in brain functioning [e.g. 
35-36].  It is thus of paramount importance to characterise and interpret appropriately allele-
dependent differences in the connectivity of a corel region like the hippocampus during such a 
clinically relevant stage, as qualitative differences in the functional architecture of the brain might 
translate into qualitative differences in the efficacy of treatments between carriers and non-carriers 
(e.g. a memory-enhancing training). 
In this study we investigated the fMRI network signature of the ApoE İ4 allele in hippocampal 
connectivity among patients suffering from very mild AD.  To do so, we implemented seed-based 
connectivity methods in a sample of patients İ4 carriers and in a sample of İ4 non-carriers.  We 
hypothesised that allele-dependent differences would exist between the two groups, and that the 
presence of the İ4 allele would be associated with a signature of connectivity involving associative 
areas which sustain high-order cognitive processing. 
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2. Material and methods 
2.1. Participants 
Sixty-one patients were referred to neurological examination between 2011 and 2014 because of 
suspected incipient cognitive decline.  On that occasion, all patients agreed on completing cognitive 
assessment and an MRI procedures (detailed below).  A proportion of these patients was diagnosed 
with very mild dementia of the AD type [37], while a proportion received a diagnosis of MCI [38].  
This latter group was followed-up over time, and progression of disease and conversion were 
monitored until early 2015.  Based on this longitudinal neurological monitoring, only patients who 
showed evidence of a clinically-established progression towards AD dementia at follow up were 
included in this study. 
A neurological examination served to rule out the presence of major exclusion criteria, which were 
set as follows: a significant disease at clinical level, history of transient ischemic attacks, a 
diagnosis of vascular brain disease of clinical severity (e.g. the presence of chronic cerebrovascular 
disease as main aetiology), a structural MRI revealing a different diagnostic entity which could 
otherwise explain the presence of cognitive symptoms, presence/diagnosis of uncontrolled seizures, 
peptic ulcer, cardiovascular disease, sick sinus syndrome, neuropathy with conduction difficulties, 
significant disabilities, proof of abnormal baseline levels of folates, vitamin B12 or thyroid-
stimulating hormone, a significant psychiatric condition, consumption of drugs for research 
purposes or with toxic effects to internal organs. 
After genetic assays, all AD SDWLHQWVFDUU\LQJDWOHDVWRQHFRS\RIWKHİ4 allele (n = 15) were 
enrolled.  None of these KDGDİ4İ4 RUDİ2İ4 genotype.  A group of non-FDUULHUVİ3İ3 only) was then 
selected from the pool of remaining patients to match the two groups as closely as possible for 
GHPRJUDSKLFFKDUDFWHULVWLFV2WKHUQRQİ4 genotypes were not included in the control sample to 
avoid cRQWDPLQDWLRQRISURWHFWLYHIDFWRUVVXFKDVLQWKHFDVHRIWKHİ2 genotype, and in an attempt to 
minimise variance in the control patient group.  All participants were Caucasian and were 
inhabitants of one of the islands within the Venetian lagoon.  This study was carried out according 
to the Declaration of Helsinki and was approved by the Institutional Review Board of the IRCCS 
Fondazione Ospedale San Camillo (Venice, Italy).  Written informed consent was obtained from 
each study participant. 
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An extensive battery of neuropsychological tests was administered to each patient as part of the 
initial diagnostic classification procedures.  This included tests assessing short- and long-term 
verbal and non-verbal memory, attention, naming by confrontation, logical abstract reasoning, 
verbal fluency and visuoconstructional abilities (see Table 1 for details). 
 
2.2. MRI Acquisition, Preprocessing and Analysis 
A structural 3D T1-weighted brain scan and two resting-state fMRI runs were acquired on a 1.5 T 
Philips Achieva system, and preprocessed and analysed using Statistical Parametric Mapping 
(SPM) 8 software (Wellcome Trust Centre for Neuroimaging, London, UK) running in Matlab 
R2011b (Mathworks Inc., UK).  T2-weighted and FLAIR-weighted sequences were also included in 
the protocol to verify neuro-anatomical exclusion criteria and suitability for inclusion in the study.  
A senior neuroradiologist reviewed each anatomical scan to ascertain study compatibility.  
Participants were asked to remain as still as possible for the full duration of the scan.  No stimuli 
were presented. 
Preprocessing of T1-weighted images was carried out using a standard Voxel-Based Morphometry 
approach [39].  Native-space volumes of grey matter, white matter, and cerebrospinal fluid were 
obtained to calculate individual brain parenchymal volume, total intracranial volume, and tissue-
class ratios (grey-matter, white-matter, and brain parenchymal fraction).  Modulated and normalised 
tissue-class maps were then smoothed with a 8 mm full-width at half maximum gaussian kernel.  
Additionally, native-space T1-weighted images were also segmented to extract the hippocampal 
maps for further sample characterisation.  For this purpose, the STEPS algorithm was implemented 
[40].  Briefly, this methodology allows an automatic and precise segmentation of the hippocampus 
by registering each scan to the most appropriate image among a series of available templates.  
Absolute and ratio-based volumetric properties of left and right hippocampus were thus extracted. 
Resting-state fMRI acquisitions were preceded by 20-seconds of dummy scans to allow the scanner 
to reach a state of electro-magnetic equilibrium.  Each run included 120 volumes of T2* weighted 
echo planar images (repetition time = 2 s, echo delay time = 50 ms, flip DQJOHƕYR[HOGLPHQVLRQV
3.28 × 3.28 × 6.00 mm3, field of view 230 mm).  Each volume included 20 contiguous axial slices, 
acquired in ascending order.  Slice-timing was carried out first.  Volumes in each run were then 
realigned and resliced independently.  Concurrently, linear and rotational parameters of head 
motion were estimated by the use of 4th Degree B-Spline interpolation.  Volumes were subsequently 
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normalised using the first realigned volume as source image to match the SPM 8 echoplanar 
template, and voxel size was re-dimensioned to 2.0 × 2.0 × 2.0 mm3.  Images were then band-pass 
filtered at 0.008 ± 0.1 Hz using the REST toolbox [41].  Finally, volume smoothing was carried out 
with a 6.0 × 6.0 × 6.0 mm3 full-width at half maximum isotropic gaussian kernel. 
Hippocampal connectivity was computed by means of seed-based first-level models.  Seed regions 
were devised based on the IBA16 atlas implemented in the WFU-Pickatlas toolbox [42].  Both left 
and right seeds were loaded on a structural template to ascertain the absence of major spatial 
misplacements over the temporal horn of the ventricles.  By doing so, miscalculations of average 
seed signal due to the presence of cerebrospinal liquid were minimised.  Signal extraction from the 
two seed regions was carried out using the MarsBaR toolbox [43].  Two additional vectors were 
extracted from the map of white matter and from that of cerebrospinal fluid.  First-level analyses 
were carried out to obtain individual maps of seed-based connectivity, regressing out the signal 
from white matter and cerebrospinal fluid, and controlling for in-scanner motion vectors.  For 
inferential analyses, a p value of 0.01 (uncorrected) was set.  Age, education levels, MMSE scores, 
and grey-matter fraction were used as covariates.  MMSE scores were included in the model to 
account for variability of disease severity, as the mechanisms of AD affect the connectivity of the 
hippocampus [44-45], while grey-matter fraction served as proxy of brain reserve.  Of all the output 
clusters only peaks surviving Family-Wise Error (FWE)-correction at a cluster level were reported 
as significant to minimise chances for Type I Errors.  Peak coordinates were converted into 
Talairach stereotaxic space thanks to a non-linear transform (http://imaging.mrc-
cbu.cam.ac.uk/downloads/MNI2tal/mni2tal-m) and interpreted using the Talairach Daemon client 
(www.talairach.org/client.htm), single-point coordinate search [46-47]. 
 
 
3. Results 
There was no significant difference in age, level of education and male/female proportion between 
the two groups.  Group comparisons revealed also no differences in absolute/proportional properties 
of brain structure.  Although global difference in white-matter ratio survived correction for multiple 
statistical comparisons (with İ4İ3 patients having a significantly higher ratio of white matter), the 
voxel-based analyses revealed no between-group differences neither in the regional maps of grey 
matter nor in those of white matter.  Moreover, all p values indicated that in our sample the two 
hippocampal regions were comparable between the two groups, as both absolute and relative 
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(fractional) volumetric values did not differ between ࠱4 carriers and non-carriers.  No between-
group difference was found in any of the raw scores obtained over the set of neuropsychological 
tests, not even when age and education were included in the analyses.  No significant differences 
were found also when age- and/or education corrected scores based on published norms were 
compared between the two groups.  Both groups of patients had had an amnestic onset as 
established by their neuropsychological profile.  Verbal declarative memory was, in fact, the 
cognitive domain in which both carriers and non-carriers showed performance levels below cut-off.  
All these between-group comparisons are reported in Table 1. 
 
- Insert Table 1 about here - 
 
Hippocampal connectivity findings are reported in Table 2 and illustrated in Fig.1.  İ4 carriers 
showed enhanced connectivity between the left hippocampus and two clusters, one located in the 
left insula extending to the inferior frontal cortex, and one located in the right inferior parietal 
lobule, with a peripheral peak located in somatosensory areas.  No differences were found in the 
functional connectivity of the right hippocampus. 
 
- Insert Fig.1 and Table 2 about here ± 
 
In order to clarify whether this allele-dependent difference in the pattern of functional connectivity 
between the hippocampus and the inferior parietal lobule was beneficial or not, this latter cluster 
was binarised, and signal extraction was carried out from this region as originally carried out for the 
two seeds.  A seed-to-target index of connectivity was then computed.  A coefficient of partial 
correlation was calculated between seed and target vectors, controlling for the same regressors as 
with the voxel-based analyses, and a )LVFKHU¶VUWR] transformation was then applied.  Since the 
recruited sample was prevalently characterised by amnestic problems, a composite index of 
memory performance was computed by transforming the corrected scores of four tests investigating 
various aspects of verbal and visuospatial memory (Rey Complex Figure Test ± Recall, Visual 
Supraspan Test, Prose Memory Test - Global Recall, and Paired Associates Test) into z-scores, 
which were then averaged for each patient.  This variable distributed normally (Shapiro-Wilk test of 
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normality p = 0.920).  A linear-regression model was then designed for both groups.  To test the 
hypothesis by which this pathway of connectivity predicted memory performance, two blocks were 
created.  The Mini-Mental State Examination score and the fractional volume of the left 
hippocampus were inputted in the first block to control for potential cognitive and neurostructural 
confounds, and the z-index of connectivity was included in the second block.  In the group of non-
carriers, the slope associated with the predictor was not significant (b = 0.131; r2-change statistic = 
0.001; p = 0.905), whereas a significant slope was found in the group of carriers (b = 0.759; r2-
change statistic = 0.211; p = 0.029; Fig.2).  This allele-dependent association did not generalise to 
other cognitive functions.  In fact, the strength of this specific pathway of connectivity did not 
predict executive performance (average of z-transformed corrected scores in the Stroop Test ± Time 
and the Letter Fluency Test) in neither of the two groups. 
 
- Insert Fig.2 about here - 
 
3.1 Validation of the results in the ADNI cohort 
To verify this pattern of group difference, an additional sample of 65 MCI patients was identified 
(30 with an İ4İ3 RUİ4İ4 genotype, and 35 with an İ3İ3 genotype) (see Table 3 for details).  These 
ZHUHREWDLQHGIURPWKH$O]KHLPHU¶V'LVHDVH1HXURLPDJLQJ,QLWLDWLYH$'1,GDWDEDVH
(adni.loni.usc.edu). The ADNI was launched in 2003 as a public-private partnership, led by 
Principal Investigator Michael W. Weiner, MD.  The primary goal of ADNI has been to test 
whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other 
biological markers, and clinical and neuropsychological assessment can be combined to measure 
WKHSURJUHVVLRQRIPLOGFRJQLWLYHLPSDLUPHQW0&,DQGHDUO\$O]KHLPHU¶VGLVHDVH$'ROI-
based analyses were carried out to compute the pattern of functional connectivity between the 
hippocampus and Brodmann areas.  Univariate ANOVAs were then run between the two groups 
controlling for age, education levels, MMSE and ventricle size. Increased functional connectivity 
ZDVIRXQGLQWKHJURXSRIİFDUULHUVLQWKHVXSUDPDUJLQDOJ\UXV(p < 0.029) and in the prefrontal 
cortex (p < 0.039), paralleling our original findings. 
 
- Insert Table 3 about here - 
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4. Discussion 
In this study, differences within the maps of hippocampal connectivity were investigated between a 
group of early stage AD patients carrying a copy of the ApoE İ4 allele, and a group of patients with 
Dİ3İ3 genotype.  The sample was extensively tested with statistical procedures in order to maximise 
comparability  along the most relevant axes of demographic, neurostructural and cognitive 
variability. 
The findings show that carriers have increased connectivity between the left hippocampus and two 
clusters, the first of which was centred in the right inferior parietal lobule.  Being the hippocampus 
and the inferior parietal lobule both hubs of the DMN [2], this piece of evidence suggests that the 
presence of the İ4 allele might be associated with a more preserved DMN in prodromal AD.  This 
trend, however, goes in the opposite direction as that emerged from the studies characterising the 
DMN when AD is more severe, in which İ4 carriers were instead found to show reduced 
connectivity within aspects of the DMN [34], and, specifically, between the hippocampus and 
prefrontal, parietal, and temporal regions [33].  As a consequence, we suggest that the ࠱4 allele 
might influence the patterns of hippocampal connectivity with a quadratic tendency.  This trend 
would not come as a novelty.  In fact, it follows the longitudinal progression of hippocampal 
function as reported by a study of task fMRI, in which activation of this region is increased in MCI 
patients during memory processes, but reduced in AD dementia [11].  Furthermore, recent evidence 
indicates that there is an inverse association between hippocampal function (as measured by FDG 
PET metabolism) and DMN connectivity (as estimated by hippocampus-to-precuneus BOLD-signal 
correlation) in patients with AD dementia, but such association is not visible in MCI [48].  These 
pieces of evidence indicate that the progressive disruption of DMN and hippocampal connectivity 
are not linear along the timeline of AD progression.  We hereby suggest that the enhanced 
hippocampus-parietal connectivity seen in the group of ࠱4 carriers reflects an intensification of this 
³QDWXUDOO\-RFFXUULQJ´SKHQRPHQRQUp-regulation of connectivity between hippocampus and left 
lateral prefrontal cortex was seen in the group of ࠱4 carriers.  The involvement of the frontal lobe as 
ApoE-dependent between-group difference has already been reported in studies of healthy 
indivLGXDOVLQZKLFKDXJPHQWHGFRQQHFWLYLW\ZDVREVHUYHGLQİ4 carriers between hubs of the DMN 
and extra areas that normally are not part of this circuit [e.g. 22, 24].  This was accounted for by the 
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hypothesis of compensatory mechanisms taking over from the AD-dependent disruption of 
³VWDQGDUG´SDWWHUQVRIFRQQHFWLYLW\7KHLGHDWKDWDIXQFWLRQDOUHRUJDQLVDWLRQRIUHJLRQDO
connectivity occurs in healthy adults with a risk factor for AD is also supported by studies of task-
associated fMRI, in which evidence of computational differences has been repeatedly reported, 
albeit with no constant pattern [49].  Our results suggest that compensatory mechanisms may be 
WULJJHUHGLQİ4 carriers even after the possible onset of neurodegeneration, or it might be the 
outcome of the brain over-time coping with the subtle negative effects of this genetic risk factor. 
At a first glance, the up-regulated connectivity between the hippocampus and the parietal lobe 
might also be compensatory in nature, as it consists of an intensification of a pattern of connectivity 
which is normally visible by default.  Despite this straight-forward interpretative remark, there is 
another potential explanations that needs to be taken into account, which suggests that the evidence 
RI³KLSSRFDPSDOK\SHUconnectivity´LVQRWQHFHVVDULO\LQGHx of compensation.  A recent 
randomised trial found that amnestic MCI patients receiving mild antiepileptic medication showed a 
significant improvement in memory performance, which associated with significantly reduced 
hippocampal activation.  As a consequence the enhanced magnitude of hippocampal function seen 
at baseline was interpreted by the authors as a dysfunctional trait [50].  Based on this same 
interpretational paradigm (albeit transposed, in a speculative way, to the construct of connectivity), 
it might be suspected that the increased connectivity seen in the DMN of ࠱4 carriers might be 
maladaptive in nature, despite being located in a functional pathway where, at least in heathy adults, 
³PRUH would be EHWWHU´  Along this plausible line, a study found increased task-based connectivity 
of hippocampal seeds in amnestic MCI patients compared with healthy adults in a set of regions 
including the prefrontal, temporal, parietal and limbic lobe [51].  Additionally, many of these 
pathways of connectivity were inversely associated with cognitive performance, as an indication of 
the dysfunctional nature of this excessive connectivity [51]. To test the conflicting hypotheses of 
compensation vs. maladaptative rewiring, we carried out post-hoc analyses to explore the 
association between the strength of the functional connectivity between the hippocampus and the 
inferior parietal lobule, and an index of memory performance.  While no association was found in 
the group of non-carriers, a positive association was found in the group of carriers, indicating that, 
compatibly with a compensatory mechanism, the more connected the two regions, the more 
productive the memory processing. 
There is evidence that increases in functional connectivity seen in AD neurodegeneration might be 
the result of a pathological interconnection of distinct network patterns.  This was reported by Wang 
and colleagues [34], who, using a graph-theory approach, found decreased levels of inter-network 
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connectivity among AD patients carriers of the ࠱4 isoform.  Conversely, Seeley and colleagues [52] 
came up with the same interpretational avenue to explain the spreading (and, therefore, increase) of 
functional connectivity of the DMN to extra-DMN structures.  Neural cerebral cortex circuitry is a 
biological system characterised by balanced involvement of parallel networks.  The DMN is 
negatively correlated with the salience network, a resting-state circuit whose activation is associated 
with the integration of sensory processing and internal autonomic-visceral processing [53].  This 
anticorrelation would reflect an inter-network balance based on mutual inhibition between the two 
circuits.  When the DMN is damaged by AD, this harmonic equilibrium would collapse, and, as a 
consequence, the anticorrelated network would no longer be inhibited.  This dihinibition would 
trigger enhanced connectivity within the anticorrelated network and reorganisation of connectivity 
patterns to induce between-network interactions [52].  Published evidence provides additional 
support for this hypothesis DVDSRWHQWLDOVLJQDWXUHRWWKHİ4 allele.  In a study of healthy older 
individuals, İ4 carriers showed more connectivity within the salience network than non-carriers 
[21].  Another stuG\RIQHWZRUNGLIIHUHQFHVDVVRFLDWHGZLWKWKHSUHVHQFHRIWKHİ4 isoform in 
middle-aged adults found diminished connectivity within structures of the DMN in carriers, 
including the left hippocampal/parahippocampal complex, the left anterior temporal pole and the 
dorsomedial prefrontal cortex bilaterally.  At the same time decreased anticorrelated connectivity 
was observed between the posterior cingulate and regions in the salience network.  
Complementarily, seed-based connectivity devised to estimate the SN revealed increased 
connectivity with DMN areas in the same group [54].  Consistently with the disinhibition 
hypothesis, we interpret the enhanced functional connectivity seen LQİ4 carriers between the seed in 
the left hippocampus (part of the DMN) and the left insula, that is one of the main hubs of the 
salience network, as maladaptive. 
These findings support the idea that allele-dependent diversity in resting-state circuitry is detectable 
even after conversion from healthy ageing to the first symptomatic phases of AD.  The various 
interpretations of differences found between the two groups converge in indicating that patients 
FDUULHUVRIWKH$SR(İ4 allele have additional circuital damage in comparison with non-carrier 
individuals.  This additional network disruption is supported by the necessity to rely on a higher 
magnitude of compensation and by the dysfunctional nature of some of the circuital rewiring.  It is 
noteworthy to highlight that no cognitive differences and no neurostructural discrepancies existed 
between the two groups of patients.  Nonetheless, circuital breakdown was more profound in the 
JURXSRIİ4 carriers.  This may have important implications in the therapeutical management of 
these patients.  Two individuals with comparable cognitive phenotype might have a diverse degree 
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of hidden circuital deterioration/dysfunction that is genotype-dependent.  A more profoundly 
damaged neural architecture might be associated to less capacity for neuroplastic changes, and some 
forms of therapeutic intervention might not be as beneficial as expected.  
These results support the view that, despite its non-linear tendency (increase of DMN connectivity 
seen in the prodromal phases, and decrease of DMN connectivity documented in the later dementia 
phases)WKHİ4-associated network disruption might be independent of disease stage.  Recent 
findings suggest that the neural representations of at least some aspects of certain cognitive 
functions are subjected to a comprehensive re-organisation in association with the development of 
MCI [55-56].  This insidious functional ³re-PRXOGLQJ´ could potentially nullify or at least minimise 
WKHGHWULPHQWDOLPSDFWRIWKHİ4 allele, which would be superseded by the impact of pathology.  Our 
study concludes that this does not occur, as the impact of genetic variability for the ApoE gene 
keeps expressing in the form of more profound condition of network disruption even after the onset 
of prodromal pathological processes.  Other findings are in line with this conclusion.  There is a 
sWURQJERG\RIHYLGHQFHVXJJHVWLQJWKDWİ4 carriers with MCI tend to have smaller hippocampi and 
DP\JGDODHWKDQSDWLHQWVQRWFDUU\LQJWKHİ4 allele but having similar demographic characteristics 
[57-60].  Other studies have instead reported volumetric loss LQİ4 carriers extending to other 
cortical and subcortical areas [61-64], although some have suggested that non-carriers can cope 
with a much more pronounced and extensive brain volume loss before manifesting the same level of 
cognitive disruption [64].  IQDGGLWLRQWKHUHLVHYLGHQFHWKDW0&,SDWLHQWVFDUU\LQJWKHİ4 isoform 
have reduced cortical metabolism bilaterally in the precuneus, the superior temporal gyrus and the 
inferior parietal lobule [65].  Albeit being in line with our findings, all these studies were based on a 
localisation-based approach.  This type of approach is not as suitable as a connectivity-based 
framework to characterise cellular and synaptic disruption, and its association to the underlying 
cognitive functions [66].  Moreover, it is worth noting that evidence emerging from connectivity 
analyses should not be taken for granted as the natural consequence of the aforementioned 
localisation-based differences reported in the literature.  Indeed, the parallel study of the impact of 
WKHİ4 allele on structural connectivity of AD patients (which describes different, yet theoretically 
contiguous aspects of signal propagation) has led to incongruous findings [67-68]. 
$OWKRXJKD³FODVVLFDO´YLHZLQGLFDWHVWKDWWKHOHIWKLSSRFDPSXVZRXOGEHPDLQOy involved in verbal 
memory processes (as opposed to the right hippocampus, inolved instead mainly in visuospatial 
memory processes), recent evidence found instead no evidence of such lateralisation [69].  On this 
note, the creation of a memory composite score based on both verbal and visuospatial memory 
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performance would be a better modality-independent estimate of real mnemonic capacities, as it is a 
value obtained averaging four and not simply two values. 
This study is not free from limitations.  First, this is a cross-sectional study.  Longitudinal 
investigations need to be planned to clarify the impact of the ApoE genotype along the axis of 
disease progression.  Second, no specific control was carried out on other relevant risk factors 
involved in AD.  Third, albeit these findings, surviving a Family-Wise Error-corrected cluster-level 
p < 0.05, show a degree of robustness against the Type I Error, larger samples are necessary to 
control further for more variables, and possibly, to investigate the impact RIWZRFRSLHVRIWKHİ4 
allele, since genotype effects might be actenuated in individuals carrying only one copy of the gene, 
and dose-dependent effects may exist.  Fourth, no information on amyloid pathology was available 
for these patients.  Although this would have not affected the diagnosis in these patients (as this had 
been reached after planned follow-up assessments over an extended period), it would have allowed 
XVWRXQGHUVWDQGZKHWKHUWKHGLIIHUHQFHVLQFRQQHFWLYLW\VKRZQE\İ4 carriers are associated with 
regional difference in amyloid deposition. 
Despite these limitations, this study highlights the role of the İallele as a modifying-factor of 
neural pathways that are relevant for AD neurodegeneration. Although these findings shed some 
DGGLWLRQDOOLJKWRQWKHUROHRIWKHİDOOHOHLQ$'WKHRYHUDOOFRQWH[WLQZKLFKWKHVHresults have to 
be inserted remains extremely complicated. The clinical role of the hippocampus is not confined to 
the sole AD, but is involved in other conditions of neurological relevance. For example, alterations 
of resting-state hippocampal blood perfusion has been described in individuals at high risk of 
psychotic symptoms [70], and abnormal increases of hippocampal connectivity are visible as a 
consequence of post-traumatic brain disorders [71]$WWKHVDPHWLPHWKHİDOOHOHZDVIRXQGWR
influence the activity and network properties of other, non-hippocampal regions, such as the 
prefrontal cortex [72] or midline structures and insula [73].  Finally, it is still unclear how the 
interplay of ApoE genotype and disease mechanisms influence not only resting-state by also task-
based functional connectivity, especially during memory retrieval processes [51]. 
 
Conclusion 
In summary, we found evidence of network spatial discrepancies between prodromal AD patients 
FDUU\LQJRQHFRS\RIWKH$SR(İ4 DOOHOHDQGSDWLHQWVKRPR]\JRXVIRUWKH$SR(İ3 allele showing no 
differences in demographic, neurostructural, and neuropsychological characteristics.  Increased 
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connectivity was seen in carriers between the left hippocampus and 1) parietal areas, 2) prefrontal 
regions, and 3) the insular cortex.  Although this pattern may be partially seen as the result of 
compensatory mechanisms (especially with regard to the increased connectivity seen in the frontal 
lobe), there are two interpretational avenues that identify these differences as maladaptive.  First the 
³K\SHUIXQFWLRQDOKLSSRFDPSXV´hypothesis suggests that the excessive seed-to-parietal connectivity 
might be dysfunctional as negatively associated with cognitive performance [48-49].  This 
eventuality was ruled out by post-hoc analyses, which confirmed that the magnitude of connectivity 
along this pathway was positively associated with memory performance (characterising it as 
compensatory).  6HFRQGWKH³GLVKLQLELWLRQK\SRWKHVLV´LQGLFDtes that excessive hippocampus-to-
insula connectivity might be result of maladaprive rewiring of a portion of the DMN with a portion 
of the salience network [50, 52].  As a consequence, the presence of maladaptive processes and the 
necessity to rely on extra compensation indicate that ࠱4 carriers show an accentuated degree of 
network involvement independent of the diagnostic group and dependent on the ApoE genotype. 
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Figure Captions 
 
Fig.1 
Pattern of enhanced functional connectivity of the left hippocampus found in patients who were 
carriers of the ࠱4 allele. Slices in MNI space are as follows: z = -10, z = 46. The seed region is 
illustrated on the left (slices in MNI space are as follows: x = -26, y = -13, z = -13). 
 
 
Fig.2 
Association between mediotemporal-parietal connectivity and memory function as investigated at 
post-hoc. On the left, the association found in the group of patients who were homozygotes for the 
࠱3 allele (r = -0.037; p = 0.905); on the right, the association found in the group of patients with an 
࠱4࠱3 genotype (r = 0.602; p = 0.029). 
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Table 1: Sample Characterisation 
 
Descriptive Variables ࠱4࠱3 ܭܭ Between-Group Statistics 
Demographic Characteristics     pt test/chi square 
Age at Scan (years) 73.20 (5.85) 73.80 (4.87) 0.762 
Education Level (years) 9.20 (4.11) 9.13 (3.56) 0.962 
Gender (f/m) 7/8 7/8 0.999 
 
   
 
Global Structural Indices   pt test 
Grey-Matter Volume (cl) 538.74 (64.45) 536.66 (59.93) 0.893 
White-Matter Volume (cl) 451.09 (65.14) 423.83 (63.69) 0.256 
Brain Parenchymal Volume (cl) 990.83 (123.53) 960.49 (114.58) 0.491 
Cerebrospinal-Fluid Volume (cl) 697.05 (122.87) 770.58 (112.12) 0.098 
Grey-Matter Fraction 0.32 (0.02) 0.31 (0.03) 0.244 
White-Matter Fraction 0.27 (0.02) 0.24 (0.02) 0.002 
Brain Parenchymal Fraction 0.59 (0.03) 0.56 (0.04) 0.012 
Total Intracranial Volume (cl) 1687.88 (231.15) 1731.07 (181.37) 0.574 
Left Hippocampal Volume (cl) 2.12 (0.37) 2.24 (0.27) 0.322 
Right Hippocampal Volume (cl) 2.24 (0.30) 2.30 (0.30) 0.543 
Left Hippocampal Fraction 2.15-3 (2.95-4) 2.35-3 (2.85-4) 0.065 
Right Hippocampal Fraction 2.27-3 (2.82-4) 2.41-3 (2.99-4) 0.190 
Hippocampal Asymmetry (left/right) 0.95 (0.10) 0.97 (0.04) 0.356 
 
    
Neuropsychological Raw Scores   pt test PCorrected ANOVA 
Mini Mental-State Examination 25.93 (3.81) 26.00 (3.21) 0.959 0.921 
Raven Progressive Matrices 26.33 (5.43) 25.00 (6.47) 0.546 0.501 
Letter Fluency Test 33.00 (11.93) 27.60 (10.36) 0.196 0.163 
Category Fluency Test 27.07 (8.52) 25.47 (6.62) 0.570 0.645 
Digit Cancellation Test 48.00 (9.18) 46.67 (9.40) 0.697 0.729 
WAIS - Similarities 17.93 (5.59) 17.13 (5.29) 0.690 0.686 
Token Test 33.57 (2.00) 33.50 (2.10) 0.930 0.927 
Rey Complex Figure Test - Copy 29.23 (3.95) 28.13 (6.36) 0.574 0.601 
Rey Complex Figure Test - Recall 8.40 (4.40) 7.87 (3.92) 0.728 0.809 
Stroop Time Interference Effect 36.43 (20.32) 40.43 (14.04) 0.536 0.547 
Stroop Error Interference Effect 1.83 (2.74) 2.60 (2.83) 0.457 0.515 
Digit Span Test - Forward 5.40 (0.74) 5.80 (0.86) 0.183 0.199 
Digit Span Test - Backwards 3.80 (0.86) 3.67 (0.62) 0.630 0.547 
Corsi Test 4.13 (0.74) 4.13 (0.74) 0.999 0.876 
Visual Supraspan Test 14.91 (7.62) 9.83 (7.66) 0.085 0.091 
Prose Memory Test - Immediate Recall 5.67 (3.73) 5.93 (3.15) 0.834 0.731 
Prose Memory Test - Delayed Recall 6.20 (4.84) 6.53 (3.85) 0.836 0.772 
Prose Memory Test - Global Recall 11.87 (8.17) 12.47 (6.60) 0.826 0.739 
Paired Associates Test 9.61 (4.27) 7.60 (2.68) 0.139 0.159 
Confrontation Naming Test 18.07 (2.12) 18.00 (1.65) 0.924 0.972 
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Neuropsychological Corrected Scores   pt test Cut-Off 
Raven Progressive Matrices 28.71 (4.28) 28.05 (6.09) 0.736  
Letter Fluency Test 37.47 (9.81) 31.87 (11.33) 0.159  
Category Fluency Test 32.00 (9.14) 31.07 (6.70) 0.752  
Digit Cancellation Test 49.22 (7.18) 46.32 (9.25) 0.346  
Token Test 31.65 (7.33) 33.68 (1.99) 0.309  
Rey Complex Figure Test - Copy 30.85 (3.71) 29.23 (6.64) 0.419  
Rey Complex Figure Test - Recall 11.93 (4.85) 12.20 (4.18) 0.873  
Stroop Time Interference Effect 26.38 (19.43) 29.48 (14.03) 0.620 ш 36.92 
Stroop Error Interference Effect 1.02 (2.25) 1.52 (2.21) 0.544 ш 4.24 
Digit Span Test - Forward 5.57 (0.69) 6.02 (0.96) 0.151  
Corsi Test 4.42 (0.74) 4.50 (0.63) 0.742  
Visual Supraspan Test 16.89 (7.24) 11.48 (7.77) 0.063  
Prose Memory Test - Global Recall 12.67 (7.29) 13.07 (6.69) 0.877  
Paired Associates Test 11.14 (3.81) 9.37 (3.01) 0.174  
Between-group statistics were run using chi square (gender), one-way ANOVA (differences in cognitive performance corrected for age and levels of 
education) and independent-sample t (all remaining comparisons) inferential models.  Hippocampal asymmetry was calculated based on the raw 
volumes computed using the STEPS protocol.  Brain parenchymal volume was computed as the sum of grey-matter and white-matter volumes. Tissue 
fractions were calculated dividing tissue class volume by total intracranial volume. Hippocampal fractions were instead calculated dividing 
KLSSRFDPSDOYROXPHVE\EUDLQSDUHQFK\PDOYROXPHV³pCorrected ANOVA´ LQGLFDWHVWKHVLJQLILFDQFHOHYHODIWHUFRYDULDWLQJIRU\HDrs of age and 
years of education. In bold the sole between-group difference surviving Bonferroni correction for multiple comparisons (pGlobal Structural Indices < 
0.0038). The aspects of cognitive functions showing performance below cut-off are instead underlined. 
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Table 2: Between-group differences in hippocampal connectivity 
 
Cluster 
Number 
Cluster Size 
(voxels) 
Cluster-
Level pFWE 
Z Value at Local 
Maximum Hemisphere Cerebral Region 
Brodmann 
Area 
Talairach Coordinates 
x y z 
1 377 0.047 3.72 L Inferior Frontal Gyrus 47 -38 15 -9 
 
  
3.44 L Insula 13 -46 12 -1 
 
  
2.62 L Inferior Frontal Gyrus 13 -32 13 -14 
2 506 0.010 3.25 R Inferior Parietal Lobule 40 40 -43 43 
 
  
3.21 R Inferior Parietal Lobule 40 38 -52 45 
      3.18 R Postcentral Gyrus 2 59 -29 42 
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Table 3: Characteristics of the sample of patients extracted from the ADNI cohort 
Descriptive Variables ܭܭ- ܭܭ ܭܭ Between-Group Statistics 
Age at Recruitment (years) 71.43 (5.61) 72.43 (7.69) 0.559 
Education Level (years) 16.70 (2.88) 15.97 (2.42) 0.272 
Gender (f/m) 12/18 17/18 0.488 
Ventricular Size (mm3) 36785.23 (20974.18) 37645.34 (240505.53) 0.879 
Mini Mental State Examination 27.50 (1.96) 28.00 (1.61) 0.263 
Rey Auditory Verbal Learning Test - Immediate Recall 36.53 (9.53) 34.34 (9.90) 0.604 
Rey Auditory Verbal Learning Test - Learning 4.37 (3.18) 4.89 (2.98) 0.318 
Between-group statistics were run using chi square (gender), one-way ANOVA (differences in cognitive performance corrected for age and levels of education) and independent-sample t (all remaining comparisons) 
inferential models 
